Press-release for stocks publishing date 2022 - 05 - 03 in the health technology sector

Prices are updated after-hours

publishing date : 2022 - 05 - 03 sector : Health technology

save search

Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals
Published: 2022-05-03 (Crawled : 14:20) - globenewswire.com
BBI | $2.12 16.04%

Health Technology

| 910.75% | O: 17.94% H: 2.52% C: -5.18%
biotech pharmaceuticals

Brickell Biotech Announces Adjournment of Annual Meeting of Stockholders
Published: 2022-05-03 (Crawled : 14:20) - globenewswire.com
BBI | $2.12 16.04%

Health Technology

| 910.75% | O: 17.94% H: 2.52% C: -5.18%
biotech meeting

Aclaris Therapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium
Published: 2022-05-03 (Crawled : 15:20) - globenewswire.com
ACRS | $1.25 1.63% 1.6% 580K

Health Technology

| -90.5% | O: -0.39% H: 3.1% C: 1.32%
immunology symposium therapeutics

Atea Pharmaceuticals to Host First Quarter 2022 Financial Results Conference Call on May 10, 2022
Published: 2022-05-03 (Crawled : 20:20) - ir.ateapharma.com
AVIR | $3.7 0.0% 220K

Health Technology

| -40.03% | O: 0.0% H: 0.0% C: -0.81%
conference results

Ocular Therapeutix™ To Present Pre-Clinical Data at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting
Published: 2022-05-03 (Crawled : 16:20) - ocutx.gcs-web.com
OCUL | $5.22 -10.92% -12.26% 9.1M

Health Technology

| 84.73% | O: 0.25% H: 0.98% C: 0.98%
pre-clinical ocular therapy preclinical

Jaguar Health Completes Final Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea (EID) in Dogs
Published: 2022-05-03 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M

Health Technology

| -60.02% | O: 2.18% H: 2.17% C: -0.41%
drug diarrhea health approval

Kala Pharmaceuticals Announces New Commercial and Medicare Coverage for EYSUVIS®
Published: 2022-05-03 (Crawled : 01:00) - biospace.com/
KALA | $6.81 0.0% 7.6K

Health Technology

| 800.0% | O: 5.82% H: 0.0% C: 0.0%
eysuvis

Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
ETON | $3.12 1.96% 1.92% 34K

Health Technology

| -10.64% | O: 2.52% H: 0.0% C: 0.0%
report results

MacroGenics Provides Update on Corporate Progress and First Quarter 2022 Financial Results
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
PRVB | $24.98 0.08% 9.1M

Health Technology

| 424.79% | O: 1.26% H: 0.0% C: 0.0%
MGNX | $15.62 -2.8% -2.88% 1M

Health Technology

| 112.12% | O: -0.66% H: 0.0% C: 0.0%
results

NextCure to Present at the BofA Securities 2022 Healthcare Conference
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
NXTC | $1.67 6.37% 5.99% 62K

Health Technology

| -63.08% | O: 0.24% H: 0.0% C: 0.0%
conference

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K

Health Technology

| 43.3% | O: -0.22% H: 0.0% C: 0.0%
conference results

Intensity Therapeutics Announces New Clinical Data in Solid Tumors for its Lead Asset, INT230-6
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M

Health Technology

| -35.67% | O: 0.36% H: 0.0% C: 0.0%
int230 therapeutics

Trial Lawyer Majed Nachawati Named to Lawdragon List of 500 Leading Plaintiff Consumer Lawyers
Published: 2022-05-03 (Crawled : 23:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -18.84% | O: -0.24% H: 0.0% C: 0.0%
500 trial

Trinity Biotech Announces the Successful Closing of its Strategic Investment and Partnership With The MiCo Group of South Korea
Published: 2022-05-03 (Crawled : 23:00) - globenewswire.com
TRIB | $1.81 -3.72% -3.87% 5.7K

Health Technology

| 50.82% | O: -1.64% H: 6.67% C: 6.67%
partnership biotech group

FDA Officials call COVID-19 the 'New Normal' in Op-Ed
Published: 2022-05-03 (Crawled : 22:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -19.66% | O: -1.01% H: 0.0% C: 0.0%
covid-19 fda

Enveric Biosciences Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
Published: 2022-05-03 (Crawled : 22:00) - prnewswire.com
ENVB | $0.8989 -4.17% -4.35% 130K

Health Technology

| 250.38% | O: 0.0% H: 1.96% C: -3.35%
distribution

Sientra to Report First Quarter 2022 Financial Results on May 12, 2022
Published: 2022-05-03 (Crawled : 22:00) - globenewswire.com
SIEN | $0.174 0.69% 3.4M

Health Technology

| -85.24% | O: 0.0% H: 5.86% C: -0.69%
report results

Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA™ DUAL PAK™ (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults
Published: 2022-05-03 (Crawled : 22:00) - globenewswire.com
PHAT | $8.98 -5.27% -5.57% 590K

Health Technology

| -33.01% | O: -3.35% H: 0.0% C: -3.47%
treatment fda approval infection infections

Aquestive Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-03 (Crawled : 22:00) - globenewswire.com
AQST | $4.11 -8.67% -9.49% 2.3M

Health Technology

| 228.47% | O: 1.46% H: 4.32% C: 2.16%
therapeutics results

Sumo Logic Appoints John D. Harkey, Jr. to Board of Directors
Published: 2022-05-03 (Crawled : 22:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology